Page 41 - JCTR-11-3
P. 41

Journal of Clinical and
            Translational Research                                              Immunogenicity and safety of flu vaccines



            Writing – review & editing: Lei Wang, Hongbo Zhang, Ze   and the associated vaccines development in China: A review.
               Chen                                               Vaccines (Basel). 2022;10:1873.
                                                                  doi: 10.3390/vaccines10111873
            Ethics approval and consent to participate
                                                               9.   Wang Y, Zhang Y, Wu H, et al. Safety and immunogenicity of
            Not applicable.                                       a quadrivalent inactivated subunit non-adjuvanted influenza
                                                                  vaccine: A  randomized, double-blind, active-controlled
            Consent for publication                               phase 1 clinical trial. Vaccine. 2021;39:3871-3878.
            Not applicable.                                       doi: 10.1016/j.vaccine.2021.05.070
            Availability of data                               10.  Tregoning JS, Russell RF, Kinnear E. Adjuvanted influenza
                                                                  vaccines. Hum Vaccin Immunother. 2018;14:550-564.
            Data are available from the corresponding author on      doi: 10.1080/21645515.2017.1415684
            reasonable request.
                                                               11.  Huang X, Feng L, Du X,  et al. Guidelines for influenza
            References                                            vaccination among healthcare workers in China.  Chin J
                                                                  Infect Control. 2023;22:871-885.
            1.   National Immunization Advisory Committee (NIAC)
               Technical Working Group (TWG), Influenza Vaccination   12.  Feng LZ, Jiang HY, Yi J, et al. Introduction and implications
               TWG. Technical guidelines for seasonal influenza   of WHO position paper: Vaccines against influenza, May
               vaccination in China (2022-2023). Zhonghua Liu Xing Bing   2022. Zhonghua Yi Xue Za Zhi. 2022;102:2315-2318.
               Xue Za Zhi. 2022;43:1515-1544.                     doi: 10.3760/cma.j.cn112137-20220518-01090
               doi: 10.3760/cma.j.cn112338-20220825-00734      13.  Nct.  Clinical Study to Evaluate Safety, Immunogenicity
            2.   Trombetta  CM,  Kistner  O,  Montomoli  E,  Viviani  S,   of Investigational Flu Vaccine Compared to an Approved
               Marchi S. Influenza viruses and vaccines: The role of   Flu Vaccine  (QIV) in Children Previously Vaccinated in
               vaccine effectiveness studies for evaluation of the benefits of   Trial V118_05; 2014.  Available from:  https://clinicaltrials.
               influenza vaccines. Vaccines (Basel). 2022;10:714.  gov/study/NCT02255409?cond=Clinical%20Study%20
                                                                  to%20Evaluate%20Safety,%20Immunogenicity%20
               doi: 10.3390/vaccines10050714                      of%20%20Investigational%20Flu%20Vaccine%20
            3.   Wang S, Dong J, Chai W,  et  al. Immunogenicity of a   Compared%20to%20an%20Approved%20Flu%20%20
               monovalent 2009 influenza A (H1N1) vaccine in infants:   Vaccine%20(QIV)%20in%20Children%20Previously%20
               Randomized, observer-masked, single-center clinical study.   Vaccinated%20in%20Trial%20%20V118_05&rank=1
               Springerplus. 2014;3:397.
                                                               14.  Becker T, Elbahesh H, Reperant LA, Rimmelzwaan GF,
               doi: 10.1186/2193-1801-3-397                       Osterhaus A. Influenza vaccines: Successes and continuing
                                                                  challenges. J Infect Dis. 2021;224:S405-S419.
            4.   Feng L, Yang P, Zhang T,  et al. Technical guidelines for
               the application of seasonal influenza vaccine in China      doi: 10.1093/infdis/jiab269
               (2014-2015). Hum Vaccin Immunother. 2015;11:2077-2101.
                                                               15.  Sullivan SG, Price OH, Regan AK. Burden, effectiveness
               doi: 10.1080/21645515.2015.1027470                 and safety of influenza vaccines in elderly, paediatric and
                                                                  pregnant populations.  Ther Adv Vaccines Immunother.
            5.   National Immunization Advisory Committee (NIAC)
               Technical Working Group (TWG), Influenza Vaccination   2019;7.
               TWG. Technical guidelines for seasonal influenza      doi: 10.1177/2515135519826481
               vaccination in China (2021-2022). Zhonghua Liu Xing Bing   16.  Grohskopf LA, Blanton LH, Ferdinands JM,  et al.
               Xue Za Zhi. 2021;42:1722-1749.
                                                                  Prevention and control of seasonal influenza with
               doi: 10.3760/cma.j.cn112338-20210913-00732         vaccines: Recommendations of the advisory committee on
                                                                  immunization practices - United States, 2022-23 influenza
            6.   2023-2024 CDC flu Vaccination Recommendations
               Adopted. 2023. Available from: https://www.cdc.gov/flu/  season. MMWR Recomm Rep. 2022;71:1-28.
               spotlights/2022-2023/flu-vaccination-recommendations-     doi: 10.15585/mmwr.rr7101a1
               adopted.htm
                                                               17.  Ainslie KEC, Haber M, Orenstein WA. Challenges in
            7.   Sekiya T, Ohno M, Nomura N, et al. Selecting and using the   estimating influenza vaccine effectiveness.  Expert Rev
               appropriate influenza vaccine for each individual. Viruses.   Vaccines. 2019;18:615-628.
               2021;13:971.
                                                                  doi: 10.1080/14760584.2019.1622419
               doi: 10.3390/v13060971
                                                               18.  Yang Z, Wang S, Li W, et al. The long-term immunogenicity
            8.   Zhang J, Nian X, Li X, et al. The epidemiology of influenza   of an inactivated split-virion 2009 pandemic influenza A


            Volume 11 Issue 3 (2025)                        35                         doi: 10.36922/JCTR025060006
   36   37   38   39   40   41   42   43   44   45   46